The Food and Drug Administration said Monday that it is proposing to expand access to experimental drugs for seriously sick patients, and would allow drug companies to charge for as yet unapproved therapies.>>> Discuss This Story
The Food and Drug Administration said Monday that it is proposing to expand access to experimental drugs for seriously sick patients, and would allow drug companies to charge for as yet unapproved therapies.>>> Discuss This Story